CHANCE Trial Early Short-Term Dual Antiplatelet Treatment for Stroke Prevention

被引：8
|
作者：
Huang, David Y. [1 ]
Eisert, Wolfgang G. [2 ]
机构：
[1] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA
[2] Hannover Med Sch, Dept Neurol, D-30175 Hannover, Germany
来源：
STROKE | 2013年 / 44卷 / 12期
关键词：
early medical intervention; ischemic attack; transient; stroke; TRANSIENT ISCHEMIC ATTACK; MINOR STROKE; EARLY RISK; CLOPIDOGREL; ASPIRIN;
D O I：
10.1161/STROKEAHA.113.003380
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：3623 / 3624
页数：2
相关论文
共 50 条
  • [41] The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy
    Kargiotis, Odysseas
    Tsivgoulis, Georgios
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (01) : 45 - 54
  • [42] A REVIEW OF THE SHORT-TERM BENEFITS OF ANTIHYPERTENSIVE TREATMENT WITH EMPHASIS ON STROKE
    DOYLE, AE
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (03) : S6 - S8
  • [43] Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke
    Zheng, Yi
    Lieschke, Franziska
    Schaefer, Jan Hendrik
    Wang, Xiaoying
    Foerch, Christian
    van Leyen, Klaus
    STROKE, 2019, 50 (12) : 3650 - 3653
  • [44] STENOSIS: Long-term single versus dual antiplatelet therapy in patients with ischaemic stroke due to intracranial atherosclerotic disease - a randomised trial
    Bhatia, Rohit
    Srivastava, M. V. Padma
    Sarkar, Risha
    Fatima, Saman
    Longkumer, Imnameren
    Garg, Ajay
    Gupta, Pooja
    Pandian, Jeyaraj Durai
    Khurana, Dheeraj
    Sylaja, P. N.
    Jain, Shweta
    Arora, Deepti
    Dhasan, Aneesh
    Sharma, Meenakshi
    BMJ NEUROLOGY OPEN, 2024, 6 (01)
  • [45] IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke
    Sykora, Marek
    Krebs, Stefan
    Miksova, Dominika
    Badic, Ines
    Gattringer, Thomas
    Fandler-Hoefler, Simon
    Marko, Martha
    Greisenegger, Stefan
    Knoflach, Michael
    Lang, Wilfried
    Ferrari, Julia
    NEUROLOGY, 2023, 101 (09) : E933 - E939
  • [46] Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial
    Xie, Xuewei
    Jing, Jing
    Wang, Anxin
    Xu, Qin
    Zhao, Xingquan
    Lin, Jinxi
    Chen, Pan
    Jiang, Yong
    Wang, Yilong
    Li, Hao
    Meng, Xia
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2025,
  • [47] Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6?mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke
    Chen, Jing
    Lin, Yanchen
    Li, Jingjing
    Zhang, Peilan
    Wang, Yuxin
    Chen, Yan
    Zhang, Chenhao
    Li, Chenhua
    MEDICINE, 2023, 102 (36) : E35099
  • [48] Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis
    Zhang, Yanli
    Wang, Xuan
    Gao, Ying
    Chen, Weiqi
    Johnston, S. Claiborne
    Amarenco, Pierre
    Bath, Philip M.
    Yan, Hongyi
    Wang, Tingting
    Yang, Yingying
    Zhou, Qi
    Wang, Mengxing
    Jing, Jing
    Wang, Chunjuan
    Wang, Yongjun
    Wang, Yilong
    Pan, Yuesong
    STROKE, 2025, 56 (01) : 46 - 55
  • [49] Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom
    Liu, Xuejun
    Jiang, Jenny
    Li, Danshi
    Horrow, Jay
    Tamada, Hiroshi
    Kahl, Anja
    Hariharan, Vignesh
    Avinav, Ankur
    Li, Xiaoyan
    CARDIOLOGY AND THERAPY, 2023, 12 (04) : 675 - 687
  • [50] Antiplatelet drugs in ischemic stroke prevention: From monotherapy to combined treatment
    Urbano, LA
    Bogousslavsky, J
    CEREBROVASCULAR DISEASES, 2004, 17 : 74 - 80
12345